OC-0279 Concurrent and adjuvant effect of bevacizumab on hypofractionated tailor-made IMRT for glioblastomas. (April 2019) - Iuchi, T.; Hara, R.; Hatano, K.; Sugiyama, T.; Togasaki, G.; Setoguchi, T.; Hasegawa, Y.; Itami, M.; Sakaida, T.